Clinical Trial Update: A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time [Phase 2]

View source ↗

Summary

This Phase 2 pediatric trial compares tacrolimus formulations Advagraf and Prograf in heart, kidney, and liver transplant recipients to assess differences in ab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Heart Transplantation, Kidney Transplantation | Phase 2 | Status: COMPLETED